Clinical Trial Update: Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating natto supplementation to prevent loss of bone mass in women soon after menopause has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Natto supplementation (Natto-derived supplement)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Perimenopausal Bone Loss | Phase 2 | Status: COMPLETED